2m 2m 2m 2m 2m 2m 2m
Healthcare Svcs (HCSG)
NASDAQ
$22.61+$0.07 (+0.31%)
Price as of Jun 23, 2026 4:10 PM EDT- $1.5BMarket Cap
- 57.62%1-Year Change
- Medical Care FacilitiesIndustry
Healthcare Svcs (HCSG)
$22.61+$0.07 (+0.31%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 1.8B +7.08% | 1.7B +2.65% | 1.7B -1.11% | 1.7B +2.94% | |
Cost of Revenue | 1.6B +7.41% | 1.5B +2.12% | 1.5B -2.65% | 1.5B +5.74% | |
Gross Profit | 239.4M +4.96% | 228.1M +6.21% | 214.7M +10.79% | 193.8M -14.56% | |
Sales and Marketing Expense | 190.9M +4.26% | 183.1M +9.77% | 166.8M +18.83% | 140.3M -18.93% | |
Research and Development Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Depreciation and Amortization Expense | 16.8M +15.04% | 14.6M +1.68% | 14.3M -6.35% | 15.3M +4.42% | |
Total Operating Expenses | 1.6B +7.41% | 1.5B +2.12% | 1.5B -2.65% | 1.5B +5.74% | |
Operating Profit | 67.9M +28.19% | 52.9M -0.22% | 53.1M +17.69% | 45.1M -27.08% | |
Interest Income | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Expense | -1.6M -75.46% | -6.4M -18.05% | -7.9M +163.01% | -3.0M +115.67% | |
Interest Income and Expense and Net | -1.6M -75.46% | -6.4M -18.05% | -7.9M +163.01% | -3.0M +115.67% | |
Total Nonoperating Income and Expense | -1.6M -75.46% | -6.4M -18.05% | -7.9M +163.01% | -3.0M +115.67% | |
Income before Taxes | 67.9M +28.19% | 52.9M -0.22% | 53.1M +17.69% | 45.1M -27.08% | |
Income Taxes | 8.8M -34.62% | 13.5M -8.18% | 14.7M +40.36% | 10.5M -34.51% | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | 59.1M +49.63% | 39.5M +2.83% | 38.4M +10.85% | 34.6M -24.49% | |
Net Income from Continuing Operations Applicable to Common | 67.9M +28.19% | 52.9M -0.22% | 53.1M +17.69% | 45.1M -27.08% | |
Basic EPS and Net Income | 0.82 +51.85% | 0.54 +3.85% | 0.52 +10.64% | 0.47 -22.95% | |
Diluted EPS and Net Income | 0.81 +52.83% | 0.53 +1.92% | 0.52 +10.64% | 0.47 -22.95% | |
Basic Weighted Average Shares | 72.4M -1.86% | 73.8M -0.72% | 74.3M -0.06% | 74.3M -0.64% | |
Diluted Weighted Average Shares | 73.0M -1.29% | 74.0M -0.47% | 74.3M -0.01% | 74.4M -0.82% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 125.2M +120.50% | 56.8M +4.50% | 54.3M +106.74% | 26.3M -62.88% | |
Short-Term Investments | 42.8M -15.36% | 50.5M -45.74% | 93.1M -2.17% | 95.2M -16.78% | |
Cash and Cash Equivalents and Short-Term Investments | 168.0M +56.52% | 107.3M -27.23% | 147.5M +21.39% | 121.5M -34.40% | |
Total Current Assets | 576.4M +3.55% | 556.7M -2.63% | 571.7M +12.40% | 508.6M -6.91% | |
Accumulated Depreciation | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Property and Plant and Equipment and Net | 27.6M -2.17% | 28.2M -2.00% | 28.8M +25.24% | 23.0M -18.24% | |
Total Long-Term Assets | 3.9M -4.57% | 4.1M +146.86% | 1.7M +103.94% | 812,000 N/A | |
Total Assets | 794.3M -1.06% | 802.8M +1.53% | 790.7M +10.07% | 718.3M -7.61% | |
Income Taxes Payable | 0 -100.00% | 8.4M +16.53% | 7.2M N/A | N/A N/A | |
Total Short-Term Debt | 0 N/A | 0 -100.00% | 25.0M 0.00% | 25.0M N/A | |
Total Current Liabilities | 170.4M -11.52% | 192.5M -11.24% | 216.9M +21.45% | 178.6M -6.54% | |
Total Long-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Long-Term Liabilities | 1.6M +313.25% | 385,000 -87.12% | 3.0M -51.31% | 6.1M -41.27% | |
Total Liabilities | 180.0M -10.24% | 200.6M -12.09% | 228.2M +22.20% | 186.7M -7.76% | |
Retained Earnings | 283.7M +26.32% | 224.6M +21.38% | 185.0M +19.75% | 154.5M -16.02% | |
Total Stockholders Equity | 510.2M +2.06% | 499.9M +9.49% | 456.6M +7.14% | 426.2M -5.86% | |
Total Shares Outstanding | 69.6M -4.93% | 73.2M -0.19% | 73.3M -1.01% | 74.1M +0.43% | |
Cash Flow | |||||
Cash from Operating Activities | 145.0M +370.64% | 30.8M -29.19% | 43.5M +632.61% | -8.2M -122.01% | |
Capital Expenditures | 5.8M -8.18% | 6.3M +17.20% | 5.4M +3.76% | 5.2M -8.39% | |
Cash from Investing Activities | -11.0M -281.96% | 6.0M +283.63% | -3.3M -227.64% | 2.6M +111.22% | |
Dividends Paid | N/A N/A | 0 N/A | 0 -100.00% | 63.4M +1.84% | |
Cash from Financing Activities | -63.3M +103.97% | -31.0M +155.45% | -12.2M -68.78% | -38.9M -52.90% | |
Financials Ratio | |||||
Gross Margin | 13.03% -1.98% | 13.29% +3.47% | 12.85% +12.03% | 11.47% -17.00% | |
Operating Margin | 3.69% +19.71% | 3.09% -2.79% | 3.17% +19.01% | 2.67% -29.16% | |
Return on Assets | 7.40% +49.29% | 4.95% -2.62% | 5.09% +9.88% | 4.63% -21.13% | |
Return on Equity | 11.69% +41.69% | 8.25% -5.10% | 8.70% +10.35% | 7.88% -19.83% | |
Revenue Growth | 7.08% +167.21% | 2.65% +338.43% | -1.11% -137.85% | 2.94% +143.68% | |
Current Ratio | 3.38 +17.03% | 2.89 +9.70% | 2.64 -7.45% | 2.85 -0.39% | |
Cash Ratio | 0.73 +149.17% | 0.29 +17.72% | 0.25 +70.29% | 0.15 -60.29% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow